Hualan Biological Bacterin Inc. (301207.SZ)
CNY 18.51
(0.16%)
CNY 18.51
(0.16%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.41 Billion | 1.82 Billion | 1.82 Billion | 2.42 Billion | 1.04 Billion | 802.73 Million |
| Cost of Revenue | 287.09 Million | 217.45 Million | 220.76 Million | 257.93 Million | 161 Million | 126.87 Million |
| Gross Profit | 2.12 Billion | 1.6 Billion | 1.6 Billion | 2.16 Billion | 887.98 Million | 675.86 Million |
| Operating Expenses | 1.11 Billion | 855.96 Million | 793.88 Million | 1 Billion | 369.09 Million | 320.84 Million |
| Selling, General and Administrative Expenses | 952.78 Million | 689.94 Million | 608.61 Million | 782.15 Million | 216.85 Million | 255.77 Million |
| Research and Development Expenses | 91.1 Million | 134.63 Million | 144.12 Million | 110.93 Million | 73.04 Million | 52.97 Million |
| Other Expenses | - | -3.15 Million | -1.22 Million | 1.9 Million | -1.27 Million | 932.23 Thousand |
| Cost and Expenses | 1.47 Billion | 1.07 Billion | 1.01 Billion | 1.26 Billion | 530.09 Million | 447.71 Million |
| Operating Income | 1.01 Billion | 592.63 Million | 706.97 Million | 1.07 Billion | 432.04 Million | 299.8 Million |
| Interest Expense | 6.18 Million | 10.69 Million | 13.31 Million | 7.98 Million | 64.84 Thousand | 43.61 Thousand |
| Income Tax Expense | 146.91 Million | 69.84 Million | 84.77 Million | 149.14 Million | 56.77 Million | 31.2 Million |
| Earnings before Tax | 1 Billion | 589.47 Million | 705.74 Million | 1.07 Billion | 432.07 Million | 301.34 Million |
| Net Income | 859.96 Million | 519.63 Million | 620.97 Million | 924.9 Million | 375.29 Million | 270.14 Million |
| Earnings Per Share Basic | 1.43 | 0.87 | 1.03 | 1.54 | 0.63 | 0.50 |
| Earnings Per Share Diluted | 1.43 | 0.87 | 1.03 | 1.54 | 0.63 | 0.50 |
| Weighted Average Shares Outstanding | 600.7 Million | 600.01 Million | 600.01 Million | 600.01 Million | 600.01 Million | 540 Million |
| Weighted Average Shares Outstanding (Diluted) | 602.42 Million | 600.01 Million | 600.01 Million | 600.01 Million | 600.01 Million | 540 Million |
| Gross Margin | 0.88 | 0.88 | 0.88 | 0.89 | 0.85 | 0.84 |
| EBIT Margin | 0.43 | 0.52 | 0.50 | 0.50 | 0.62 | 0.56 |
| Profit Margin | 0.36 | 0.28 | 0.34 | 0.38 | 0.36 | 0.34 |
| EBITDA | 1.02 Billion | 741.88 Million | 789.73 Million | 1.11 Billion | 444.04 Million | 306.25 Million |
| Earnings Before Tax Margin | 0.42 | 0.32 | 0.39 | 0.44 | 0.41 | 0.37 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 916.94 Million | -584.95 Thousand | 34.22 Million | 688.16 Million | 2.39 Billion | 1.56 Billion |
| Cost of Revenue | 172.64 Million | 40.42 Million | 3.4 Million | 99.21 Million | 333.78 Million | 200.6 Million |
| Gross Profit | 744.29 Million | -41.01 Million | 30.81 Million | 588.95 Million | 2.06 Billion | 1.36 Billion |
| Operating Expenses | 493.24 Million | 6.6 Million | 50.15 Million | 350.22 Million | 1.17 Billion | 721.32 Million |
| Selling, General and Administrative Expenses | 459.56 Million | -11.32 Million | 33.07 Million | 245.34 Million | - | 724.62 Million |
| Research and Development Expenses | 33.67 Million | 17.93 Million | 19.02 Million | 9.96 Million | - | 20.12 Million |
| Other Expenses | - | 761.57 Thousand | -184.24 Thousand | -94.91 Million | -116.11 Million | -849.08 Thousand |
| Cost and Expenses | 665.88 Million | 47.03 Million | 53.56 Million | 449.43 Million | 1.51 Billion | 921.92 Million |
| Operating Income | 251.05 Million | -47.61 Million | 43.49 Million | 238.72 Million | 881.93 Million | 611.32 Million |
| Interest Expense | 1.53 Million | 1.53 Million | 1.33 Million | 1.7 Million | 6.08 Million | 1.41 Million |
| Income Tax Expense | 38.65 Million | -4.83 Million | 4.71 Million | 41.69 Million | 146.91 Million | 88.98 Million |
| Earnings before Tax | 280.74 Million | -18.15 Million | 43.3 Million | 271.95 Million | 1 Billion | 610.47 Million |
| Net Income | 242.08 Million | -13.31 Million | 38.58 Million | 230.25 Million | 859.96 Million | 521.49 Million |
| Earnings Per Share Basic | 0.40 | -0.02 | 0.06 | 0.38 | - | 0.87 |
| Earnings Per Share Diluted | 0.40 | -0.02 | 0.06 | 0.38 | - | 0.87 |
| Weighted Average Shares Outstanding | 598.81 Million | 598.81 Million | 600.14 Million | 600.01 Million | 600.01 Million | 600.01 Million |
| Weighted Average Shares Outstanding (Diluted) | 598.81 Million | 598.81 Million | 601.08 Million | 600.01 Million | 600.01 Million | 600.01 Million |
| Gross Margin | 0.81 | 70.11 | 0.90 | 0.86 | 0.86 | 0.87 |
| EBIT Margin | 0.31 | 21.40 | 0.04 | 0.40 | - | 0.42 |
| Profit Margin | 0.26 | 22.76 | 1.13 | 0.33 | 0.36 | 0.33 |
| EBITDA | 282.27 Million | -12.51 Million | 1.4 Million | 274.65 Million | - | 665.81 Million |
| Earnings Before Tax Margin | 0.27 | 81.41 | 1.27 | 0.35 | 0.37 | 0.39 |
0K05
004770
007390
030530
ATRAV
C3RY